A Study On The Efficacy Of Macugen Injections In Patients With Neovascular Age-Related Macular Degeneration In Real Life.

• Status: Completed
• Trial end date: 2009-10-01
• Target enrollment: 0
• Participant gender: All

Summary

To assess effectiveness of Macugen for treatment of neovascular age-related macular degeneration by measuring the evolution of visual acuity. Treatment duration, frequency of administration and combination with other treatments will also be evaluated.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer

Criteria

Inclusion Criteria:

• Patients diagnosed with subfoveal neovascular (wet) age-related macular degeneration

• Patients having received at least 1 Macugen injection

• Treatment naive patients, or patients having received conventional therapy

• Patients having signed and dated informed consent.

Exclusion Criteria:

• Patients participating in another clinical study with Macugen.